OKYO Pharma (OKYO) Prepaid Assets (2023 - 2025)

OKYO Pharma (OKYO) reported Prepaid Assets of $394367.0 for Q3 2025, up 23.46% year-over-year from $319437.0 in Q3 2024, and up 74.99% quarter-over-quarter from $225360.0 in Q1 2025.

OKYO Pharma (OKYO) Prepaid Assets (2023 - 2025) Analysis & Trends

OKYO Pharma (OKYO) has 3 years of Prepaid Assets data on file, last reported at $394367.0 in Q3 2025.

  • Prepaid Assets for Q3 2025 came in at $394367.0, up 23.46% year-over-year; the trailing twelve-month figure through Sep 2025 was $394367.0 (up 23.46% YoY), and the FY2025 annual result was $225360.0, up 73.19% from the prior year.
  • Prepaid Assets advanced to $394367.0 in Q3 2025 per OKYO's latest filing, from $225360.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $394367.0 in Q3 2025 and troughed at $130126.0 in Q1 2024.
  • A 3-year average of $264567.6 and a median of $253548.0 in 2023 frame the typical range for Prepaid Assets.
  • On a YoY basis, Prepaid Assets climbed as much as 73.19% in 2025 and fell as far as 23.46% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $253548.0 in 2023, then rose by 25.99% to $319437.0 in 2024, then climbed by 23.46% to $394367.0 in 2025.
  • Business Quant data shows OKYO's Prepaid Assets at $394367.0 in Q3 2025, $225360.0 in Q1 2025, and $319437.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 OKYO Pharma 244.98 Mn 240.76 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 394,367.00
Mar 31, 2025 225,360.00
Sep 30, 2024 319,437.00
Mar 31, 2024 130,126.00
Sep 30, 2023 253,548.00